Researchers conducted a retrospective study of US patients with gastric cancer to determine what factors influenced the use of preoperative chemotherapy in this patient population.
Investigators sought to determine why so few biospecimens were available for research from minority populations of women with breast cancer.
Researchers at Memorial Sloan-Kettering Cancer Center sought to determine if observation status may be a better treatment option for older adults with cancer who present to the ED.
A cancer diagnosis often further stigmatizes gay men, particularly those who have not revealed their sexual orientation to others. In this review, CancerCare's Bill Goeren discusses the psychosocial challenges inherent to cancer care for gay men.
Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic GroupsJune 23, 2017
Follow-up after abnormal results on mammography is more likely to be delayed among Asian American women compared with white women, and varies between different Asian ethnicities.
A new report from ACS describes trends in liver cancer and the factors influencing the ongoing increase in incidence, particularly higher rates of HCV infection, obesity, and type 2 diabetes.
Liver cancer mortality has increased at a faster pace than other cancers in the United States, but substantial disparities exists in mortality rates for race/ethnicity and state of residence.
More public tolerance for health care inequalities has been observed in the United States than other countries.
ACS colorectal cancer statistics show an overall decrease in incidence due to increases in screening rates; however, age-related incidence is trending up in younger persons, down in older persons.
NCI awarded a $9 million grant to Barbara A. Karmanos Cancer Institute and Wayne State University to explore factors contributing to racial disparities in cancer.
Living in a high-poverty region is associated with lower access to obesity-related self-care resources.
The site of cancer care may partially explain survival differences between children and AYAs with ALL.
Investigators determined the impact of socioeconomic status on disease status at presentation and survival among patients with head and neck squamous cell carcinoma.
Despite that most patients with newly diagnosed prostate cancer receive high-quality care, a racial disparity exists, a recent study has shown.
Researchers from the University of Miami School of Business Administration and the Florida Atlantic University College of Business present an overview of the impact of the ACA on US health care in its first 5 years.
Health Care Reform Has No Impact on Role of Safety-Net Hospitals in Providing Care to Minority Patient PopulationsJuly 08, 2016
After implementation of health insurance reforms in Massachusetts that also expanded access to care to non-safety-net hospitals, researchers found that minority-serving hospitals are vital to providing care for these patient populations.
The number of patients older than 75 years who do not undergo surgery is increasing, especially among those with stage III or IV ovarian cancer. Approximately 50% do not undergo surgery and 25% receive no treatment at all.
Readmission Rates at Hospitals After Cancer-Related Procedures Is Too Complex for Simple Reimbursement RulesJune 17, 2016
Rates of readmission to hospitals after complex cancer surgeries are usually higher in vulnerable hospitals that serve as safety nets in their communities or in hospitals with a large number of Medicaid-insured patients.
The global economic downturn of 2008-2010, accompanied by a sharp rise in unemployment, is associated with more than 260 000 excess deaths due to cancers, many of which are considered treatable.
Differences in Cancer Rates Seen Among Asian American and Native Hawaiian/Pacific Islander PopulationsJanuary 29, 2016
Significant differences in cancer rates were found between Asian Americans and Native Hawaiians/Pacific Islanders (AANHPIs), according to a special report within Cancer Facts & Figures 2016.
Medicaid benefits are an important part of the health care landscape for low-income cancer survivors.
Concurrent but unrelated diseases in AYAs with cancer have been identified and documented. The index measures the impact of comorbidities on health care services needs and the general health status of this patient population.
A presentation during the 57th American Society of Hematology (ASH) Annual Meeting examined the pros and cons of value-based purchasing.
Patients with breast cancer whose health insurance plans included prescription drug benefits were 10% more likely to start important hormonal therapy than patients who did not have prescription drug coverage.
Affordable Care Act (ACA) Impacts Stage at Diagnosis and Fertility-Sparing Treatment in Young Women With Cervical CancerNovember 30, 2015
Both the stage of cervical cancer at diagnosis and the receipt of fertility-sparing treatment among young women age 21 to 25 years, but not among women age 26 to 34 years, is associated with the Affordable Care Act Dependent Coverage Expansion provision.
New and better drugs to treat diseases such as advanced breast cancer will have little effect on improving patient outcomes if a country does not have good health care structures in place.
Researchers have taken a new approach to understanding why so many patients with breast cancer in Appalachia are not getting the care they need, and their findings are set to change how people view the obstacles to receiving care that beset the region.
Variation in Medicare reimbursement for radiation therapy not attributed to patient or cancer characteristicsSeptember 03, 2015
Differences in radiation therapy costs for Medicare patients often have little to do with patient specifics, researchers found.
A patient navigator program was successful in lowering the rate of missed appointments for cervical cancer evaluation following a Pap smear by twenty percent.
The percentage of patients with early stage breast cancer undergoing breast-conserving therapy (BCT) increased from 54.3% in 1998 to 60.1% in 2011, according to a recent report. Notably, nonclinical factors including socioeconomic demographics, insurance, and the distance patients must travel to treatment facilities persist as key barriers to the treatment.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|